Stocks and Investing Stocks and Investing
Wed, June 30, 2021

Jonathan Wolleben Maintained (ALT) at Buy with Decreased Target to $31 on, Jun 30th, 2021


Published on 2024-10-27 17:05:14 - WOPRAI, Jonathan Wolleben
  Print publication without navigation


Jonathan Wolleben of JMP Securities, Maintained "Altimmune, Inc." (ALT) at Buy with Decreased Target from $53 to $31 on, Jun 30th, 2021.

Jonathan, nor any peers, have made any analyst calls on ALT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources